IDO1 and breast carcinoma: IDO was mainly expressed in cancer cells in breast cancer PTs and expressed at lower levels in certain myeloid cell-like karyocytes in TDLNs and hyperplastic ductal cells in benign diseases, but not expressed in normal adjacent tissues.